Gemcitabine for Injection 1 g (Gemcitabine (Gemcitabine Hydrochloride) POWDER FOR SOLUTION) 1 G

Gemcitabine for Injection 1 G is a powder for solution used in intravenous therapy. This medication is commonly associated with cancer treatment protocols. It is manufactured by Accord Healthcare Inc. in Canada.

Strength

1 G

Pack Size

Manufacturer / TM Owner

ACCORD HEALTHCARE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine for Injection 1 G is primarily used in the treatment of various types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Gemcitabine used for?' This medication is typically administered intravenously and is part of a broader cancer treatment plan.

Side Effects

Common effects of Gemcitabine for Injection 1 G may include fatigue, nausea, and a decreased white blood cell count. These effects can vary among individuals and are generally managed under medical supervision. Patients should report any severe or persistent side effects to their healthcare provider.

Precautions & Warnings

Gemcitabine for Injection 1 G should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines to ensure safety. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Gemcitabine for Injection 1 G may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this medication.

Frequently Asked Questions

Gemcitabine is primarily used in the treatment of various types of cancer as part of chemotherapy regimens.

Gemcitabine for Injection 1 G is administered intravenously, typically in a clinical setting under medical supervision.

Common side effects may include fatigue, nausea, and a decreased white blood cell count. Severe or persistent effects should be reported to a healthcare provider.

Yes, Gemcitabine may interact with other medications, especially those that affect the immune system or blood cell production.

Patients should follow proper storage and administration guidelines and inform their healthcare provider about any existing medical conditions or allergies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.